Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Estimating Methods of the Undetected Infections in the COVID-19 Outbreak: A Systematic Review

Author(s): Esmaeil Mehraeen, Zahra Pashaei, Fatemeh Khajeh Akhtaran, Mohsen Dashti, Arian Afzalian, Afsaneh Ghasemzadeh, Pooria Asili, Mohammad Saeed Kahrizi, Maryam Mirahmad, Ensiyeh Rahimi, Parisa Matini, Amir Masoud Afsahi, Omid Dadras and SeyedAhmad SeyedAlinaghi*

Volume 23, Issue 4, 2023

Published on: 08 March, 2023

Article ID: e240123213106 Pages: 18

DOI: 10.2174/1871526523666230124162103

Price: $65

Abstract

Introduction: The accurate number of COVID-19 cases is essential knowledge to control an epidemic. Currently, one of the most important obstacles in estimating the exact number of COVID-19 patients is the absence of typical clinical symptoms in a large number of people, called asymptomatic infections. In this systematic review, we included and evaluated the studies mainly focusing on the prediction of undetected COVID-19 incidence and mortality rates as well as the reproduction numbers, utilizing various mathematical models.

Methods: This systematic review aims to investigate the estimating methods of undetected infections in the COVID-19 outbreak. Databases of PubMed, Web of Science, Scopus, Cochrane, and Embase, were searched for a combination of keywords. Applying the inclusion/exclusion criteria, all retrieved English literature by April 7, 2022, were reviewed for data extraction through a two-step screening process; first, titles/abstracts, and then full-text. This study is consistent with the PRISMA checklist.

Results: In this study, 61 documents were retrieved using a systematic search strategy. After an initial review of retrieved articles, 6 articles were excluded and the remaining 55 articles met the inclusion criteria and were included in the final review. Most of the studies used mathematical models to estimate the number of underreported asymptomatic infected cases, assessing incidence and prevalence rates more precisely. The spread of COVID-19 has been investigated using various mathematical models. The output statistics were compared with official statistics obtained from different countries. Although the number of reported patients was lower than the estimated numbers, it appeared that the mathematical calculations could be a useful measure to predict pandemics and proper planning.

Conclusion: In conclusion, our study demonstrates the effectiveness of mathematical models in unraveling the true burden of the COVID-19 pandemic in terms of more precise, and accurate infection and mortality rates, and reproduction numbers, thus, statistical mathematical modeling could be an effective tool for measuring the detrimental global burden of pandemic infections. Additionally, they could be a really useful method for future pandemics and would assist the healthcare and public health systems with more accurate and valid information.

Keywords: Undetected infections, COVID-19, sampling, snowball sampling, network-based sampling, clinical symptoms.

Graphical Abstract

[1]
Monshi MMA, Poon J, Chung V. Deep learning in generating radiology reports: A survey. Artif Intell Med 2020; 106: 101878.
[http://dx.doi.org/10.1016/j.artmed.2020.101878] [PMID: 32425358]
[2]
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 2020; 323(20): 2052-9.
[http://dx.doi.org/10.1001/jama.2020.6775] [PMID: 32320003]
[3]
Susilo A, Rumende CM, Pitoyo CW, et al. Coronavirus disease 2019: Tinjauan literatur terkini. J Penyakit Dalam Indonesia 2020; 7(1): 45-67.
[http://dx.doi.org/10.7454/jpdi.v7i1.415]
[4]
Diagnosis and treatment plan of corona virus disease 2019 (tentative sixth edition). Glob Health J 2020; 4(1): 1-5.
[5]
Oliaei S. SeyedAlinaghi S, Mehrtak M, et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. Eur J Med Res 2021; 26(1): 96.
[6]
Mehraeen E, Dadras O, Afsahi AM, et al. Vaccines for COVID-19: A systematic review of feasibility and effectiveness. Infect Disord Drug Targets 2022; 22(2): e230921196758.
[http://dx.doi.org/10.2174/1871526521666210923144837] [PMID: 34554905]
[7]
Melis M, Littera R. Undetected infectives in the COVID-19 pandemic. Int J Infect Dis 2021; 104: 262-8.
[http://dx.doi.org/10.1016/j.ijid.2021.01.010] [PMID: 33434673]
[8]
Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382(12): 1177-9.
[http://dx.doi.org/10.1056/NEJMc2001737] [PMID: 32074444]
[9]
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020; 323(14): 1406-7.
[http://dx.doi.org/10.1001/jama.2020.2565] [PMID: 32083643]
[10]
Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(14): 411-5.
[http://dx.doi.org/10.15585/mmwr.mm6914e1] [PMID: 32271722]
[11]
Ocagli H, Azzolina D, Lorenzoni G, et al. Using social networks to estimate the number of COVID-19 cases: The incident (hidden COVID-19 cases network estimation) study protocol. Int J Environ Res Public Health 2021; 18(11): 5713.
[http://dx.doi.org/10.3390/ijerph18115713] [PMID: 34073448]
[12]
Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection. Ann Intern Med 2020; 173(5): 362-7.
[http://dx.doi.org/10.7326/M20-3012] [PMID: 32491919]
[13]
Nishiura H, Kobayashi T, Miyama T, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020; 94: 154-5.
[http://dx.doi.org/10.1016/j.ijid.2020.03.020] [PMID: 32179137]
[14]
Cavallo JJ, Donoho DA, Forman HP. Hospital capacity and operations in the coronavirus disease 2019 (COVID-19) pandemic-planning for the nth patient. JAMA Health Forum 2020; 1(3): e200345.
[15]
Moghadas SM, Shoukat A, Fitzpatrick MC, et al. Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proc Natl Acad Sci USA 2020; 117(16): 9122-6.
[http://dx.doi.org/10.1073/pnas.2004064117] [PMID: 32245814]
[16]
Forecasting the impact of the first wave of the COVID-19 pandemic on hospital demand and deaths for the USA and European economic area countries. medRxiv 2020; 2020.04.21.20074732.
[17]
Akhmetzhanov AR, Mizumoto K, Jung SM, Linton NM, Omori R, Nishiura H. Estimation of the actual incidence of coronavirus disease (COVID-19) in emergent hotspots: The Example of Hokkaido, Japan during February-March 2020. J Clin Med 2021; 10(11): 2392.
[http://dx.doi.org/10.3390/jcm10112392] [PMID: 34071502]
[18]
Baccini M, Cereda G, Viscardi C. The first wave of the SARS-CoV-2 epidemic in Tuscany (Italy): A SI2R2D compartmental model with uncertainty evaluation. PLoS ONE 2021; 16(4)
[19]
Bö hning D, Rocchetti I, Maruotti A, Holling H. Estimating the undetected infections in the COVID-19 outbreak by harnessing capture–recapture methods. Int J Infect Dis 2020; 97: 197-201.
[http://dx.doi.org/10.1016/j.ijid.2020.06.009] [PMID: 32534143]
[20]
Devkota JU. Estimation of underreported cases of infections and deaths from COVID-19 for countries with limited and scarce data: Examples from Nepal. J Environ Public Health 2022; 2022. Available from: https://www.hindawi.com/journals/jeph/2022/3276583/
[21]
Huo X, Chen J, Ruan S. Estimating asymptomatic, undetected and total cases for the COVID-19 outbreak in Wuhan: A mathematical modeling study. BMC Infect Dis 2021; 21(1): 476.
[http://dx.doi.org/10.1186/s12879-021-06078-8] [PMID: 34034662]
[22]
Ivorra B. Ferrández MR, Vela-Pérez M, Ramos AM. Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections. The case of China. Commun Nonlinear Sci Numer Simul 2020; 88: 105303.
[http://dx.doi.org/10.1016/j.cnsns.2020.105303] [PMID: 32355435]
[23]
James A, Plank MJ, Binny RN, et al. A structured model for COVID-19 spread: modelling age and healthcare inequities. Math Med Biol 2021; 38(3): 299-313.
[http://dx.doi.org/10.1093/imammb/dqab006] [PMID: 34002201]
[24]
Mahajan A, Solanki R, Sivadas N. Estimation of undetected symptomatic and asymptomatic cases of COVID-19 infection and prediction of its spread in the USA. J Med Virol 2021; 93(5): 3202-10.
[http://dx.doi.org/10.1002/jmv.26897] [PMID: 33620096]
[25]
Purkayastha S, Kundu R, Bhaduri R, et al. Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India. BMC Res Notes 2021; 14(1): 262.
[http://dx.doi.org/10.1186/s13104-021-05652-2] [PMID: 34238344]
[26]
Rippinger C, Bicher M, Urach C, et al. Evaluation of undetected cases during the COVID-19 epidemic in Austria. BMC Infect Dis 2021; 21(1): 70.
[http://dx.doi.org/10.1186/s12879-020-05737-6] [PMID: 33441091]
[27]
Rocchetti I. Böِhning D, Holling H, Maruotti A. Estimating the size of undetected cases of the COVID-19 outbreak in Europe: an upper bound estimator. Epidemiol Methods 2020; 9(s1): 20200024.
[http://dx.doi.org/10.1515/em-2020-0024]
[28]
Kupek E. How many more? Under-reporting of the COVID-19 deaths in Brazil in 2020. Trop Med Int Health 2021; 26(9): 1019-28.
[http://dx.doi.org/10.1111/tmi.13628] [PMID: 34008266]
[29]
Lee C, Apio C, Park T. Estimation of undetected asymptomatic covid-19 cases in South Korea using a probabilistic model. Int J Environ Res Public Health 2021; 18(9): 4946.
[http://dx.doi.org/10.3390/ijerph18094946] [PMID: 34066512]
[30]
Mourad A, Mroue F, Taha Z. Stochastic mathematical models for the spread of COVID-19: a novel epidemiological approach. Math Med Biol 2022; 39(1): 49-76.
[31]
Yuan HY, Hossain MP, Wen TH, Wang MJ. Assessment of the fatality rate and transmissibility taking account of undetected cases during an unprecedented COVID-19 surge in Taiwan. BMC Infect Dis 2022; 22(1): 271.
[http://dx.doi.org/10.1186/s12879-022-07190-z] [PMID: 35307035]
[32]
Ngondiep E. A robust numerical two-level second-order explicit approach to predicting the spread of COVID-2019 pandemic with undetected infectious cases. J Comput Appl Math 2022; 403: 113852.
[http://dx.doi.org/10.1016/j.cam.2021.113852] [PMID: 34629699]
[33]
Nkwayep CH, Bowong S, Tsanou B, Alaoui MAA, Kurths J. Mathematical modeling of COVID-19 pandemic in the context of sub-Saharan Africa: A short-term forecasting in Cameroon and Gabon. Math Med Biol 2022; 39(1): 1-48.
[34]
Oliver M, Georges D, Prieur C. Spatialized epidemiological forecasting applied to COVID-19 pandemic at departmental scale in France. MedRxiv 2021.
[http://dx.doi.org/10.1101/2021.11.03.21265855]
[35]
Gaeta G. A simple SIR model with a large set of asymptomatic infectives. Mathematics in Engineering 2021; 3(2): 1-39.
[http://dx.doi.org/10.3934/mine.2021013]
[36]
Picchiotti N, Salvioli M, Zanardini E, Missale F. COVID-19 pandemic: a mobility-dependent SEIR model with undetected cases in Italy, Europe, and US. Epidemiol Prev 2020; 44 (Suppl. 2): 136-43.
[37]
Barbarossa MV, Fuhrmann J, Meinke JH, et al. Modeling the spread of COVID-19 in Germany: Early assessment and possible scenarios. PLoS ONE 2020; 15(9)
[38]
Saberi M, Hamedmoghadam H, Madani K, et al. Accounting for underreporting in mathematical modeling of transmission and control of COVID-19 in Iran. Front Phys (Lausanne) 2020; 8: 289.
[http://dx.doi.org/10.3389/fphy.2020.00289]
[39]
Deo V, Grover G. A new extension of state-space SIR model to account for underreporting – An application to the COVID-19 transmission in California and Florida. Results Phys 2021; 24: 104182.
[http://dx.doi.org/10.1016/j.rinp.2021.104182] [PMID: 33880323]
[40]
Benrhmach G, Namir K, Bouyaghroumni J. Modelling and simulating the novel coronavirus with implications of asymptomatic carriers Int J Differ Equations 2020; 2020
[http://dx.doi.org/10.1155/2020/5487147]
[41]
Guo Z, Xiao D. Epidemiological analysis of asymptomatic SARS-CoV-2 transmission in the community: an individual-based model. Sci Rep 2021; 11(1): 6251.
[http://dx.doi.org/10.1038/s41598-021-84893-4] [PMID: 33737558]
[42]
Khan ZS, Van Bussel F, Hussain F. A predictive model for COVID-19 spread – with application to eight US states and how to end the pandemic. Epidemiol Infect 2020; 148: e249.
[http://dx.doi.org/10.1017/S0950268820002423] [PMID: 33028445]
[43]
Aravamuthan S, Reyes JFM, Dopfer D. Real-time estimation and forecasting of COVID-19 cases and hospitalizations in wisconsin HERC regions for public health decision making processes. Int J Infect Dis 2022; 116: S28-9.
[http://dx.doi.org/10.1016/j.ijid.2021.12.068]
[44]
Hirk R, Kastner G, Vana L. Investigating the dark figure of COVID-19 cases in Austria: Borrowing from the decode genetics study in Iceland. Austrian J Stat 2020; 49(5): 1-17.
[http://dx.doi.org/10.17713/ajs.v49i4.1142]
[45]
De Simone A, Piangerelli M. A Bayesian approach for monitoring epidemics in presence of undetected cases. Chaos Solitons Fractals 2020; 140: 110167.
[http://dx.doi.org/10.1016/j.chaos.2020.110167] [PMID: 32868967]
[46]
Parker MRP, Li Y, Elliott LT, Ma J, Cowen LLE. Under-reporting of COVID-19 in the northern health authority region of British Columbia. Can J Stat 2021; 49(4): 1018-38.
[http://dx.doi.org/10.1002/cjs.11664] [PMID: 34898817]
[47]
De Salazar PM, Niehus R, Taylor A, Buckee COF, Lipsitch M. Identifying locations with possible undetected imported severe acute respiratory syndrome coronavirus 2 cases by using importation predictions. Emerg Infect Dis 2020; 26(7): 1465-9.
[http://dx.doi.org/10.3201/eid2607.200250] [PMID: 32207679]
[48]
Fellows M, Paye V, Alencar A, et al. Under-reporting of COVID-19 cases among indigenous peoples in Brazil: A new expression of old inequalities. Front Psychiatry 2021; 12: 638359.
[http://dx.doi.org/10.3389/fpsyt.2021.638359] [PMID: 33912084]
[49]
Fernández-Fontelo A, Moriña D, Cabaña A, Arratia A, Puig P. Estimating the real burden of disease under a pandemic situation: The SARS-CoV2 case. PLoS ONE 2020; 15(12)
[50]
Unnikrishnan J, Mangalathu S, Kutty RV. Estimating under-reporting of COVID-19 cases in Indian states: an approach using a delay-adjusted case fatality ratio. BMJ Open 2021; 11(1): e042584.
[http://dx.doi.org/10.1136/bmjopen-2020-042584] [PMID: 33472784]
[51]
Fiedler J, Moritz CP, Feth S, Speckert M. Dreßler K, Schöِbel A. A mathematical model to estimate the number of unreported SARS-CoV-2 infections in the early phase of the pandemic using Germany and Italy as examples. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021; 64(9): 1067-75.
[http://dx.doi.org/10.1007/s00103-021-03384-z] [PMID: 34297161]
[52]
Armstrong E, Runge M, Gerardin J. Identifying the measurements required to estimate rates of COVID-19 transmission, infection, and detection, using variational data assimilation. Infect Dis Model 2021; 6: 133-47.
[http://dx.doi.org/10.1016/j.idm.2020.10.010] [PMID: 33163738]
[53]
Emery JC, Russell TW, Liu Y, et al. The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. eLife 2020; 9: e58699.
[http://dx.doi.org/10.7554/eLife.58699] [PMID: 32831176]
[54]
Vaid S, Cakan C, Bhandari M. Using machine learning to estimate unobserved COVID-19 infections in North America. J Bone Joint Surg Am 2020; 102(13): e70.
[http://dx.doi.org/10.2106/JBJS.20.00715] [PMID: 32618918]
[55]
Fochesato A, Simoni G, Reali F, Giordano G, Domenici E, Marchetti L. A retrospective analysis of the COVID-19 pandemic evolution in Italy. Biology (Basel) 2021; 10(4): 311.
[http://dx.doi.org/10.3390/biology10040311] [PMID: 33917920]
[56]
Saha S, Saha S. The impact of the undetected COVID-19 cases on its transmission dynamics. Indian J Pure Appl Math 2021; 52(4): 1229-34.
[http://dx.doi.org/10.1007/s13226-021-00035-6]
[57]
Shah MRT, Ahammed T, Anjum A, Chowdhury AA, Suchana AJ. Finding the real COVID-19 case-fatality rates for SAARC countries. Biosafety Health 2021; 3(3): 164-71.
[http://dx.doi.org/10.1016/j.bsheal.2021.03.002] [PMID: 33748737]
[58]
Veiga e Silva L, de Andrade Abi Harb MDP, Teixeira Barbosa dos Santos AM, et al. COVID-19 mortality underreporting in Brazil: Analysis of data from government internet portals. J Med Internet Res 2020; 22(8): e21413.
[http://dx.doi.org/10.2196/21413] [PMID: 32730219]
[59]
Stadler RN, Maurer L, Aguilar-Bultet L, et al. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections. Antimicrob Resist Infect Control 2021; 10(1): 44.
[http://dx.doi.org/10.1186/s13756-021-00912-z] [PMID: 33640031]
[60]
Killeen GF, Kearney PM, Perry IJ, Conroy N. Long, thin transmission chains of severe acute respiratory syndrome coronavirus 2 may go undetected for several weeks at low to moderate reproduction numbers: Implications for containment and elimination strategy. Infect Dis Model 2021; 6: 474-89.
[http://dx.doi.org/10.1016/j.idm.2021.02.002] [PMID: 33644500]
[61]
Moghadas SM, Fitzpatrick MC, Shoukat A, Zhang K, Galvani AP. Simulated identification of silent COVID-19 infections among children and estimated future infection rates with vaccination. JAMA Netw Open 2021; 4(4): e217097.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.7097] [PMID: 33890990]
[62]
Albani V, Loria J, Massad E, Zubelli J. COVID-19 underreporting and its impact on vaccination strategies. BMC Infect Dis 2021; 21(1): 1111.
[http://dx.doi.org/10.1186/s12879-021-06780-7] [PMID: 34711190]
[63]
Barrie MB, Lakoh S, Kelly JD, et al. SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: A cross-sectional, nationally representative, age-stratified serosurvey. BMJ Glob Health 2021; 6(11): e007271.
[http://dx.doi.org/10.1136/bmjgh-2021-007271] [PMID: 34764148]
[64]
Bhatia S, Imai N, Cuomo-Dannenburg G, et al. Estimating the number of undetected COVID-19 cases among travellers from mainland China. Wellcome Open Res 2020; 5: 143.
[http://dx.doi.org/10.12688/wellcomeopenres.15805.2] [PMID: 34632083]
[65]
Zhao S, Musa SS, Lin Q, et al. Estimating the unreported number of novel coronavirus (2019-ncov) cases in China in the first half of January 2020: A data-driven modelling analysis of the early outbreak. J Clin Med 2020; 9(2): 388.
[http://dx.doi.org/10.3390/jcm9020388] [PMID: 32024089]
[66]
Comiskey CM, Snel A, Banka PS. First back-calculation and infection fatality multiplier estimate of the hidden prevalence of COVID-19 in Ireland. Eur J Public Health 2021; 31(4): 908-12.
[http://dx.doi.org/10.1093/eurpub/ckab126] [PMID: 34245277]
[67]
Ma WC, Zhang P, Zhao X, Xue LY. The coupled dynamics of information dissemination and SEIR-based epidemic spreading in multiplex networks. In: Physica a-Statistical Mechanics and Its Applications. 2022; p. 588.
[68]
Tiwari S, Vyasarayani CP, Chatterjee A. Data suggest COVID-19 affected numbers greatly exceeded detected numbers, in four European countries, as per a delayed SEIQR model. Sci Rep 2021; 11(1): 8106.
[69]
Bhaduri R, Kundu R, Purkayastha S, et al. Extending the susceptible-exposed-infected-removed (SEIR) model to handle the false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy. Stat Med 2022; 41(13): 2317-37.
[http://dx.doi.org/10.1002/sim.9357] [PMID: 35224743]
[70]
Kumar RP, Basu S, Ghosh D, Santra PK, Mahapatra GS. Dynamical analysis of novel COVID-19 epidemic model with non-monotonic incidence function. J Public Affairs 2021; e2754.
[71]
Kamra N, Zhang Y, Rambhatla S, Meng C, Liu Y. PolSIRD: Modeling epidemic spread under intervention policies. J Healthc Inform Res 2021; 5(3): 231-48.
[http://dx.doi.org/10.1007/s41666-021-00099-3] [PMID: 34151134]
[72]
Baccini M, Mattei A, Rocco E, Vannucci G, Mealli F. Evaluating a SARS-CoV-2 screening strategy based on serological tests. Epidemiol Prev 2020; 44(5-6) (Suppl. 2): 193-9.
[PMID: 33412810]
[73]
Bhaduri R, Kundu R, Purkayastha S, Kleinsasser M, Beesley LJ, Mukherjee B. Extending the susceptible-exposed-infected-removed(seir) model to handle the high false negative rate and symptom-based administration of COVID-19 diagnostic tests: SEIR-fansy. medRxiv 2020.
[http://dx.doi.org/10.1101/2020.09.24.20200238]
[74]
Lazzizzera I. The SIR model towards the data. Eur Phys J Plus 2021; 136(8): 802.
[http://dx.doi.org/10.1140/epjp/s13360-021-01797-y] [PMID: 34377623]
[75]
Gu X, Mukherjee B, Das S, Datta J. COVID-19 prediction in south africa: Estimating the unascertained cases- the hidden part of the epidemiological iceberg. medRxiv 2021.
[76]
Tiwari V, Deyal N, Bisht NS. Mathematical modeling based study and prediction of COVID-19 epidemic dissemination under the impact of lockdown in India. Front Phys (Lausanne) 2020; 8: 586899.
[http://dx.doi.org/10.3389/fphy.2020.586899]
[77]
Asili P, Mirahmad M, Tabatabaei-Malazy O, et al. Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review. Daru 2021; 29(2): 449-67.
[http://dx.doi.org/10.1007/s40199-021-00422-8] [PMID: 34762250]
[78]
Harko T, Lobo FSN, Mak MK. Exact analytical solutions of the Susceptible-Infected-Recovered (SIR) epidemic model and of the SIR model with equal death and birth rates. Appl Math Comput 2014; 236: 184-94.
[http://dx.doi.org/10.1016/j.amc.2014.03.030]
[79]
Wang H, Paulson KR, Pease SA, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet 2022; 399(10334): 1513-36.
[http://dx.doi.org/10.1016/S0140-6736(21)02796-3] [PMID: 35279232]
[80]
Perone G. The determinants of COVID-19 case fatality rate (CFR) in the Italian regions and provinces: An analysis of environmental, demographic, and healthcare factors. Sci Total Environ 2021; 755(Pt 1): 142523.
[http://dx.doi.org/10.1016/j.scitotenv.2020.142523] [PMID: 33022464]
[81]
Pachetti M, Marini B, Giudici F, et al. Impact of lockdown on COVID-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America. J Transl Med 2020; 18(1): 338.
[http://dx.doi.org/10.1186/s12967-020-02501-x] [PMID: 32878627]
[82]
Stefanelli P, Bella A, Fedele G, et al. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study. Clin Microbiol Infect 2021; 27(4): 633.
[83]
Colbourn T. Unlocking UK COVID-19 policy. Lancet Public Health 2020; 5(7): e362-3.
[http://dx.doi.org/10.1016/S2468-2667(20)30135-3] [PMID: 32502388]
[84]
Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med 2020; 17(9): e1003346.
[http://dx.doi.org/10.1371/journal.pmed.1003346] [PMID: 32960881]
[85]
Mehraeen E, Oliaei S. SeyedAlinaghi S, et al. COVID-19 in pediatrics: A systematic review of current knowledge and practice. Infect Disord Drug Targets 2022; 22(5): 47-57.
[86]
Mehraeen E, Najafi Z, Hayati B, et al. Current treatments and therapeutic options for COVID-19 patients: A systematic review. Infect Disord Drug Targets 2022; 22(1): e260721194968.
[87]
Asadollahi-Amin A, Nowroozi A, Hasibi M, et al. COVID-19 and alcohol misuse: A case report. Infect Disord Drug Targets 2021; 21(8): e160921191123.
[88]
Dadras O. SeyedAlinaghi S, Karimi A, et al. COVID-19 mortality and its predictors in the elderly: A systematic review. Health Sci Rep 2022; May 23 5(3): e657.
[89]
Dadras O, Afsahi AM, Pashaei Z, et al. The relationship between COVID-19 viral load and disease severity: A systematic review. Immun Inflamm Dis 2022; 10(3): e580.
[90]
SeyedAlinaghi S, Abbasian L, Solduzian M, et al. Predictors of the prolonged recovery period in COVID-19 patients: A cross-sectional study. Eur J Med Res 2021; 26(1): 41.
[91]
SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. Late complications of COVID-19; A systematic review of current evidence. Arch Acad Emerg Med 2021; 9(1): e14.
[92]
SeyedAlinaghi S. Ghadimi M, Gharabaghi MA, Ghiasvand F. Constrictive pericarditis associated with coronavirus disease 2019 (COVID-19): A case report. Infect Disord Drug Targets 2021; 21(7): e160921188928.
[93]
Mehraeen E, Salehi MA, Behnezhad F, Moghaddam HR. SeyedAlinaghi S. Transmission modes of COVID-19: A systematic review. Infect Disord Drug Targets 2021; 21(6): e170721187995.
[94]
Ghiasvand F. SeyedAlinaghi S, Tirgar S, Salehi MR, Moradmand-Badie B. A patient with COVID-19 pneumonia presenting with plural effusion: A case report. Infect Disord Drug Targets 2021; 21(6): e170721187994.
[95]
Liu Y, Gayle AA, Wilder-Smith A. Rocklöِv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020; 27(2): TAAA021.
[http://dx.doi.org/10.1093/jtm/taaa021] [PMID: 32052846]

Rights & Permissions Print Cite
Article Metrics
18
4
© 2024 Bentham Science Publishers | Privacy Policy